Intellia reports Phase 3 “Haelo” success
World’s first in vivo gene editing readout shows “significant” efficacy… New data suggests permanent fix for hereditary angioedema swelling… Stock expected to move as analysts cite “derisking” of entire gene-tech sector… Webcast at 8:00 AM ET confirms safety profile meets …